News

News

 

 

Inside Dolomite Labs: Double Emulsions for FACS

3rd November 2020

Microfluidic technology offers a platform for enhancing biological research, allowing the encapsulation of biological cells and molecules in nano or pico-litre volumes. Read our Expert's review of the state of the art of microfluidics-based FACS applications. 

Read more

Inside Dolomite Labs: Double Emulsions for FACS

Discovering novel structural color mechanisms with microfluidics

30th July 2020

Researchers from the Pennsylvania State University use Dolomite Microfluidics’ chips to manufacture multiphase droplets to research the structural color mechanisms of various materials.

Read more

Discovering novel structural color mechanisms with microfluidics

Inside Dolomite Labs: Polystyrene particles synthesis

21st July 2020

Read about our recently developed methodology for the high-throughput synthesis of monodisperse polystyrene beads via droplet microfluidic methods using either UV or thermal curing.

Read more

Inside Dolomite Labs: Polystyrene particles synthesis

Successful collaboration achieves accurate prediction of microfluidic bead production

9th June 2020

Read more about LEXMA's unique software – MOEBIUS – which simulates the production of PLGA droplets in Aqua-Phase, and accurately predicts the trends in bead manufacture reported by Dolomite Microfluidics in the "Continuous Synthesis of Monodisperse PLGA Particles using Droplets" Application Note.

Read more

Successful collaboration achieves accurate prediction of microfluidic bead production

Microfluidics enables reliable siRNA drug delivery for inflammatory diseases and tumor targeting

4th May 2020

Researchers in the Department of Pharmacy at the Ludwig Maximilian University of Munich are using chips from Dolomite Microfluidics to reliably and consistently manufacture monodisperse nanoparticles for targeted delivery of small interfering RNA (siRNA) therapeutics.

Read more

Microfluidics enables reliable siRNA drug delivery for inflammatory diseases and tumor targeting